144 related articles for article (PubMed ID: 2878367)
1. Cancer chemotherapy. Progress in understanding multidrug resistance.
Stark GR
Nature; 1986 Dec 4-10; 324(6096):407-8. PubMed ID: 2878367
[No Abstract] [Full Text] [Related]
2. Molecular mechanism of multidrug resistance in tumor cells.
Roninson IB
Clin Physiol Biochem; 1987; 5(3-4):140-51. PubMed ID: 2887329
[TBL] [Abstract][Full Text] [Related]
3. The multidrug resistance phenotype in human cancer.
Cordon-Cardo C; O'Brien JP
Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363
[No Abstract] [Full Text] [Related]
4. [Glycoprotein in multidrug-resistant malignancies--clinical implications].
Ellis A; Lishner M; Manor J; Ravid M
Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806
[No Abstract] [Full Text] [Related]
5. Multidrug resistance.
Moscow JA; Cowan KH
Cancer Chemother Biol Response Modif; 1991; 12():91-109. PubMed ID: 1681846
[No Abstract] [Full Text] [Related]
6. Multiple drug resistance in cancer therapy.
Schneider E; Cowan KH
Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
[No Abstract] [Full Text] [Related]
7. Multidrug resistance.
Moscow JA; Cowan KH
Cancer Chemother Biol Response Modif; 1990; 11():97-114. PubMed ID: 1977437
[No Abstract] [Full Text] [Related]
8. Multidrug resistance.
Gerlach JH; Kartner N; Bell DR; Ling V
Cancer Surv; 1986; 5(1):25-46. PubMed ID: 2885085
[TBL] [Abstract][Full Text] [Related]
9. On the origins of clinical drug resistance.
O'Brien JP; Cordon-Cardo C
Semin Cancer Biol; 1991 Aug; 2(4):227-33. PubMed ID: 1680494
[TBL] [Abstract][Full Text] [Related]
10. [GP-170 glycoprotein and resistance to chemotherapy].
Lazarowski AJ
Medicina (B Aires); 1991; 51(3):279-80. PubMed ID: 1687986
[No Abstract] [Full Text] [Related]
11. [Multidrug resistance (MDR)].
Wada M; Hasegawa S; Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1994 Jun; 21(7):936-44. PubMed ID: 8002631
[TBL] [Abstract][Full Text] [Related]
12. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
13. Molecular interrelationships in multidrug resistance (review).
Kellen JA
Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy update.
Miaskowski C
Nurs Clin North Am; 1991 Jun; 26(2):331-9. PubMed ID: 2047287
[TBL] [Abstract][Full Text] [Related]
16. The reversal of multidrug resistance in cancer (review).
Kellen JA
Anticancer Res; 1993; 13(4):959-61. PubMed ID: 8352566
[TBL] [Abstract][Full Text] [Related]
17. [Role of multi-drug resistance in genito-urinary tumors].
Theyer G; Hamilton G
Prog Urol; 1993 Jun; 3(3):385-92; discussion 392-3. PubMed ID: 8103698
[No Abstract] [Full Text] [Related]
18. Modes of resistance to antitumor agents.
Kessel D
In Vivo; 1994; 8(5):829-34. PubMed ID: 7727732
[TBL] [Abstract][Full Text] [Related]
19. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
Fox E; Bates SE
Expert Rev Anticancer Ther; 2007 Apr; 7(4):447-59. PubMed ID: 17428165
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
Pasman PC; Schouten HC
Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]